Paper39882155
Photodynamic Therapy Mediated by Curcumin and Blue Light for Recurrent Herpes Labialis: A Case Report.
Khalil M and 1 other. Clin Case Rep, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Photodynamic Therapy Mediated by Curcumin and Blue Light for Recurrent Herpes Labialis: A Case Report. Papers, record 39882155. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39882155
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Photodynamic Therapy Mediated by Curcumin and Blue Light for Recurrent Herpes Labialis: A Case Report.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9700525 | Photodynamic antimicrobial chemotherapy (PACT). | J Antimicrob Chemother | 1998 | https://conductscience.org/library/papers/9700525 | PubMed |
| 2 | 33212267 | Photodynamic therapy and Acyclovir in the treatment of recurrent herpes labialis: A controlled randomized clinical trial. | Photodiagnosis Photodyn Ther | 2021 | https://conductscience.org/library/papers/33212267 | PubMed |
| 3 | 28681068 | Photodynamic Therapy with Red Light and 5-Aminolaevulinic Acid for Herpes Simplex Recurrence: Preliminary Results. | Acta Derm Venereol | 2017 | https://conductscience.org/library/papers/28681068 | PubMed |
| 4 | 31932389 | Efficacy of a topical herbal and mineral formulation (Dynamiclear) for the treatment of herpes simplex labialis in the community setting: study protocol for a randomised, double-blind placebo-controlled trial. | BMJ Open | 2020 | https://conductscience.org/library/papers/31932389 | PubMed |
| 5 | 32195950 | Treatment of herpes labialis by photodynamic therapy: Study protocol clinical trial (SPIRIT compliant). | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/32195950 | PubMed |
| 6 | 29378256 | Curcumin-mediated Photodynamic Therapy for the treatment of oral infections-A review. | Photodiagnosis Photodyn Ther | 2018 | https://conductscience.org/library/papers/29378256 | PubMed |
| 7 | 37505438 | Acyclovir-resistant HSV-1 isolates among immunocompromised patients in southern Taiwan: Low prevalence and novel mutations. | J Med Virol | 2023 | https://conductscience.org/library/papers/37505438 | PubMed |
| 8 | 30274257 | Photodynamic Inactivation of Herpes Simplex Viruses. | Viruses | 2018 | https://conductscience.org/library/papers/30274257 | PubMed |
| 9 | 31648056 | "Efficacy of photodynamic therapy on the treatment of herpes labialis: A systematic review". | Photodiagnosis Photodyn Ther | 2020 | https://conductscience.org/library/papers/31648056 | PubMed |
| 10 | 32998270 | Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32998270 | PubMed |
| 11 | 18197856 | Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features. | J Oral Pathol Med | 2008 | https://conductscience.org/library/papers/18197856 | PubMed |
| 12 | 25900893 | Genotoxic effect of photodynamic therapy mediated by curcumin on Candida albicans. | FEMS Yeast Res | 2015 | https://conductscience.org/library/papers/25900893 | PubMed |
| 13 | 33894370 | Effectiveness of photodynamic therapy as an adjunct to topical antiviral therapy in the treatment of herpes labialis: A randomized controlled clinical trial. | Photodiagnosis Photodyn Ther | 2021 | https://conductscience.org/library/papers/33894370 | PubMed |
| 14 | 34800566 | Antimicrobial blue light: A 'Magic Bullet' for the 21st century and beyond? | Adv Drug Deliv Rev | 2022 | https://conductscience.org/library/papers/34800566 | PubMed |
| 15 | 11160032 | The many challenges of facial herpes simplex virus infection. | J Antimicrob Chemother | 2001 | https://conductscience.org/library/papers/11160032 | PubMed |
| 16 | 16008638 | Psychometric properties of the Brazilian version of the Oral Health Impact Profile-short form. | Community Dent Oral Epidemiol | 2005 | https://conductscience.org/library/papers/16008638 | PubMed |
| 17 | 33572685 | Nutraceutical Curcumin with Promising Protection against Herpesvirus Infections and Their Associated Inflammation: Mechanisms and Pathways. | Microorganisms | 2021 | https://conductscience.org/library/papers/33572685 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42737488 | Coumarin and Curcumin-Metal Complexes as Next-Generation Photosensitizers in Cancer Photodynamic Therapy. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737488 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39882155
GET https://conductscience.org/api/papers/v1/39882155/authors